EICHORCondition: Analgesia · Sponsor: Heron Therapeutics
This is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 sequential parts: Part 1 is randomized and Part 2 is Investigator's preference for MMA regimen.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Anaheim Clinical Trials, LLC | Anaheim, California, United States | — |
| Horizon Clinical Research | La Mesa, California, United States | — |
| Sharp Grossmont Hospital | La Mesa, California, United States | — |
| University of California, Irvine Medical Center | Orange, California, United States | — |
| Parkview Community Hospital | Riverside, California, United States | — |
| Yale University School of Medicine | New Haven, Connecticut, United States | — |
| Medical Research of Westchester, Inc | Miami, Florida, United States | — |
| Professional Health Care of Pinellas | St. Petersburg, Florida, United States | — |
| University of Louisville Hospital | Louisville, Kentucky, United States | — |
| Baylor University Medical Center | Dallas, Missouri, United States | — |
| Washington University School of Medicine | St Louis, Missouri, United States | — |
| Rutgers - New Jersey Medical School | Newark, New Jersey, United States | — |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03907176